Abhishek Ghosh
The healthcare landscape will see an overhaul in 2024, driven by the powerful duo of digital transformation and Generative Artificial Intelligence (GenAI). While AI has been making waves in healthcare for years, GenAI, characterized by its ability to create new content and data, unlocks unprecedented possibilities. According to a recent McKinsey paper, GenAI is predicted to unlock a piece of the unrealized $1 trillion improvement potential present in the industry.
However, when it comes to implementing these revolutionary technologies, the industry must tread carefully – ensuring adherence to ethical and legal issues related to data privacy, consent, and confidentiality as required by HIPAA, addressing patient safety concerns due to inherent biases in AI models, and fostering interoperability within the healthcare ecosystem.
Here are some of the latest Generative AI trends based on what our experts think are poised to overhaul the healthcare and life sciences industry in 2024:
1. Precision Medicine Tailored to Your DNA
Personalized medicine, long a science fiction trope, is becoming a reality with GenAI. In 2024, we'll see a surge in GenAI models analyzing a patient's genetic dataset along with medical history to identify genetic markers for diseases, a patient’s risk of developing certain diseases, disease progression, predicting individual responses to medication and preparing tailored treatment plans.
Next Generation Sequencing (NGS) tests are important advances in the clinical applications of precision medicine. These new sequencing techniques contain the equivalent of millions of tests in one. NGS tests can be used to sequence multiple genes at once, identify disease-associated variants to help match patients to therapies or assess disease risk, and help target therapies and reduce overall care costs.
It is genuinely significant that you code alongside each opportunity you get.
To reap the full benefits, the insights generated by these tests need to seamlessly integrate with existing EHR systems, allowing healthcare providers to make informed decisions based on a holistic view of the patient’s health history. For example, insights could be used to identify patients who are at risk of developing chronic conditions, such as diabetes or heart disease, and provide targeted interventions to prevent the onset of these conditions. Insights could also be used to identify patients who are at risk of adverse drug reactions and provide alternative treatment options. By leveraging insights from genetic test results, healthcare providers can take a more personalized approach to patient care that improves health outcomes and reduces healthcare costs.
A recent report by Accenture predicts a 25% increase in the use of genomics for personalized medicine by 2026.
2. Drug Discovery on Fast Forward
The painstakingly slow process of drug discovery is getting a GenAI overhaul. By analyzing mountains of chemical compounds and biological data, GenAI models can predict potential drug candidates and simulate their interactions with the human body. The potential of GenAI in drug discovery is further exemplified by Pfizer's success. By leveraging AI tools, they achieved an impressive end-to-end clinical success rate of 21%, showcasing the technology's ability to accelerate and streamline the development process.
McKinsey & Company revealed that 90% of BioPharma and MedTech leaders anticipate GenAI profoundly impacting their research and development efforts in 2024.However, ensuring interoperability between AI platforms and pharmaceutical research databases is crucial for sharing and verifying data efficiently. It fosters collaboration and accelerates the drug discovery process, ultimately bringing life-saving medications to patients faster.
3. Surgery Reimagined with Virtual Rehearsals
Imagine practicing a complex surgery on a digital twin of the patient before making the first incision. That's the promise of GenAI in surgical planning. A 2023 Statista report forecasts the global surgical simulation market to reach an impressive $2.1 billion by 2027.
By generating realistic 3D models of organs and tissues, GenAI allows surgeons to virtually rehearse procedures, optimize their approach, and identify potential complications beforehand. However, integrating these 3D models with existing surgical planning software and ensuring HIPAA compliance for patient data used in simulations are crucial considerations.
4. Bioprinting Organs for the Waiting List
Every ten minutes, a name is added to the national organ and tissue transplant waiting list, and every day, twenty people die waiting for a transplant. Bioprinting organs for the waiting list refers to the process of creating artificial organs using 3D printing technology.
The organ donor shortage could become a relic of the past with the advent of bioprinting. Bioprinting is currently used to create living tissue for research purposes. AI will help in the bioprinting process by analyzing data and identifying patterns at every stage of the 3D bioprinting process, which can lead to the production of biocompatible tissues that are tailored to a patient’s physiological makeup.
While this holds immense promise, ethical considerations surrounding the use of patient data and the long-term safety of bio-printed organs need careful evaluation. Apart from that, fostering interoperability between bioprinting facilities and transplant centers is crucial for streamlining the organ allocation process.
5. AI-powered Companions Combating Loneliness
Loneliness is a growing epidemic with detrimental health consequences. In 2024, AI will offer companionship and combat social isolation, especially for vulnerable populations like the elderly. However, ensuring that these AI companions are HIPAA-compliant and respect user privacy is paramount. Additionally, integrating them with existing telehealth platforms and EHR systems can allow healthcare providers to monitor patients remotely and intervene if needed. A 2022 report by the National Academies of Sciences, Engineering, and Medicine cited research showing that AI companions can improve social engagement, cognitive function, and overall well-being in older adults.
As we enter 2024 with GenAI poised to revolutionize healthcare, navigating the ethical, regulatory, and interoperability landscape is crucial. By upholding HIPAA principles, ensuring seamless EHR integration, and fostering data exchange across platforms, we can harness the power of GenAI to deliver personalized, efficient, and ethical healthcare for all. The future of wellness beckons, and it's our responsibility to ensure everyone has access to its transformative potential.
